Polymorphic N-acetylation capacity in lung cancer
- 1 March 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 9 (3) , 491-493
- https://doi.org/10.1093/carcin/9.3.491
Abstract
Hepatic N -acetylation phenotype has been suggested to be an important risk factor in the aetiology of bladder cancer. This study explores the N -acetylation capacity of a series of lung cancer cases (126) and two control groups. No overall association of slow or rapid acetylators exists between cancer patients and controls. There is also no difference in the distribution of acetylation phenotypes amongst the histological subtypes.This publication has 1 reference indexed in Scilit:
- Influence of age, sex and body weight on the dapsone acetylation phenotype.British Journal of Clinical Pharmacology, 1987